Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
RAD | Ann: Notice Under Section 708A | 15/04/24 | 0 | 181 | |||
|
|||||||
RAD | Ann: Application for quotation of securities - RAD | 15/04/24 | 0 | 121 | |||
|
|||||||
RAD | Ann: Results of Extraordinary General Meeting | 15/04/24 | 0 | 200 | |||
|
|||||||
RAD | Ann: Presentation to Extraordinary General Meeting | 15/04/24 | 0 | 189 | |||
|
|||||||
RAD | Ann: Final Director's Interest Notice MB | 12/04/24 | 16 | 4.6K | |||
|
|||||||
RAD | Ann: Initial Director's Interest Notice PH | 26/03/24 | 0 | 260 | |||
|
|||||||
RAD | Ann: Board Changes | 26/03/24 | 1 | 727 | |||
|
|||||||
RAD | Ann: RAD to present at NWR Virtual Healthcare Conference | 24/03/24 | 3 | 1.4K | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |